The landscape of dementia diagnosis has advanced considerably with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years before indications emerge. While these technological advancements symbolize remarkable progress in understanding neurodegenerative disorders, they've not diminished... https://judyd197dnx7.wikikali.com/user